About this episode:
In this podcast, Dr Penny Heaton, Global Head of the Johnson and Johnson Office of the Chief Medical Officer, discusses: 

• J&J’s approach to patient centricity across the enterprise
• Her thoughts on balancing balancing safety and risk/benefit ratios with more engaged patients and more complex science
• Moving risk benefit assessments earlier into clinical development and the necessary change management
• Incorporating multiple streams of data for the purpose of creating medicines that truly address patient needs in the real world

For more information, go to PatientsasPartnersConference.com.